DNAJB8 is a member of the DnaJ/Hsp40 family of molecular co-chaperones. It works with Hsp70 family proteins to facilitate protein folding, prevent aggregation, and target misfolded proteins for degradation. As part of the cellular protein quality control machinery, DNAJB8 is increasingly relevant to age-related neurodegenerative diseases characterized by protein aggregation.
DNAJB8 is a J-domain containing co-chaperone that partners with Hsp70 family proteins. The Hsp70/Hsp40 chaperone system is crucial for maintaining proteostasis, preventing protein aggregation, and targeting damaged proteins for degradation. In neurodegenerative diseases, these protein quality control systems become overwhelmed, making chaperones like DNAJB8 potential therapeutic targets.
| Property |
Value |
| Protein Name |
DNAJB8 (DnaJ Heat Shock Protein Family Member B8) |
| Gene |
DNAJB8 |
| UniProt ID |
Q8N5M4 |
| PDB Structure |
Predicted; no experimental structure |
| Molecular Weight |
~35 kDa |
| Subcellular Localization |
Cytosol, mitochondria (isoform-dependent) |
| Protein Family |
DnaJ/Hsp40 family |
DNAJB8 has the typical J-domain protein architecture:
¶ J Domain
- Highly conserved J motif
- HPD sequence motif essential for Hsp70 interaction
- Stimulates Hsp70 ATPase activity
- Flexible linker region
- May interact with client proteins
¶ C-Terminal Client-Binding Domain
- Substrate-binding region
- Variable among J proteins
- Determines client specificity
- J domain recruits and stimulates Hsp70
- Helps Hsp70 bind to misfolded proteins
- Prevents protein aggregation
- Facilitates protein refolding
- Part of the Hsp70/Hsp40 chaperone system
- Targets aggregation-prone proteins
- May deliver proteins to proteasome or autophagy
- Important for clearing damaged proteins
- Protects against oxidative stress
- May have role in mitochondrial quality control
- Expressed in stem cells and certain somatic tissues
- Protein aggregation is a hallmark (amyloid, tau)
- DNAJB8 may help clear aggregation-prone proteins
- Chaperone expression may be altered in AD
- Therapeutic potential as a co-chaperone
- Alpha-synuclein aggregation in Lewy bodies
- DNAJB8 can interact with alpha-synuclein
- May help prevent aggregation
- Mitochondrial quality control relevance
- Protein aggregation in motor neurons
- TDP-43 aggregation is a hallmark
- DNAJB8 may protect against aggregation
- Chaperone systems generally impaired in ALS
- Arimoclomol: Hsp70 co-inducer in clinical trials for ALS
- 17-DMAG: Hsp90 inhibitor affects Hsp70 system
- May enhance DNAJB8 function indirectly
- Viral vector delivery of chaperones
- Under investigation for neurodegenerative diseases
- Watowich & Morimoto, The Hsp40 molecular chaperone family (2008)
- Kampinga & Craig, The Hsp70 chaperone family (2010)